etoro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-OTLK-Outlook Therapeutics Inc

Outlook Therapeutics Inc OTLK

‎$‎0.3651-0.03(-7.80%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
Consensus
Moderate Buy
Price Target
4.00
Based on analysts who covered OTLK
Invest in Outlook Therapeutics Inc
Today
Create an etoro account to buy OTLK stock on a secure, user-friendly, multi-asset trading platform.
Outlook Therapeutics Inc OTLK
Buy Outlook Therapeutics Inc

OTLK Stock Price Chart

‎-25.53‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset negative trend

The Outlook Therapeutics Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Outlook Therapeutics Inc share price today is ‎$‎0.3651, reflecting a ‎-7.80‎% change over the last 24 hours and ‎-19.85‎% over the past week. The current market capitalization of OTLK is ‎$‎96.41M with an average volume in the last three months of 6.7M. The stock has a P/E ratio of -0.36 and a dividend yield of 0%. With the stock’s beta sitting at 1.16
OTLK Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎96.41M

Day’s Range
i
Shows the high and low prices of the day.
‎$‎0.35 - ‎$‎0.385

52W Range
i
Shows the high and low prices of the last year.
‎$‎0.35 - ‎$‎0.5958

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
6.7M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-0.36

Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎1.51M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎0.396

EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-1.09

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.16

How can I buy Outlook Therapeutics Inc stocks?

To purchase Outlook Therapeutics Inc:
01

Create an etoro account:

Sign up for an etoro account and verify your identity.
02

Deposit funds:

Deposit funds into your etoro account using your preferred payment method.
03

Search and purchase:

Search the Outlook Therapeutics Inc (OTLK) page and place an order to buy Outlook Therapeutics Inc.
Looking for more information? Check out our guide on Academy.
What Is Outlook Therapeutics Inc?
Outlook Therapeutics Inc is an American biopharmaceutical company focused on developing therapies for retinal diseases. Its primary aim is to provide innovative treatments for conditions affecting sight. The company operates globally, addressing unmet medical needs in ophthalmic care.

Operating within the pharmaceutical sector, Outlook Therapeutics Inc specialises in ophthalmic medications. Its specific approach involves developing biologics to improve vision and prevent blindness. The intended outcome is to offer patients more effective and accessible treatment options for serious eye conditions.

Keep up to date on the latest share price changes by adding OTLK stock to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
CEO
Robert Charles Jahr, MBA
Employees
17
Founded
2010
HQ
Iselin, New Jersey, US
Invest in Outlook Therapeutics Inc
Today
Create an etoro account to buy OTLK stock on a secure, user-friendly, multi-asset trading platform.
Buy Outlook Therapeutics Inc

FAQ

The current price of OTLK is ‎$‎0.3651.
The average price target for Outlook Therapeutics Inc is ‎$‎4.00. Sign up to etoro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Outlook Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Outlook Therapeutics Inc is ‎$‎96.41M
Based on 0 analysts offering recommendations for OTLK in the last 3 months, the overall consensus is Moderate Buy.
Scroll to top